Quest Diagnostics is a venture capital fund specializing in Series B investments in biotech and health tech. Their investments, typically ranging from $500,000 to $10 million, support companies focused on disease identification and treatment. A notable investment is in Universal Diagnostics. Leveraging a vast database of clinical results and an extensive testing network, Quest Diagnostics aims to improve health outcomes and empower healthcare organizations and clinicians.
